Page last updated: 2024-08-24

lamivudine and serine

lamivudine has been researched along with serine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
North, TW; Preston, BD; Remington, KM; Schinazi, RF; Smith, RA	1
Klarmann, GJ; North, TW; Preston, BD; Schinazi, RF; Smith, RA; Stray, KM; von Schwedler, UK	1

Other Studies

2 other study(ies) available for lamivudine and serine

Article	Year
A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine. Journal of virology, 1998, Volume: 72, Issue:3 Topics: Amino Acid Sequence; Animals; Binding Sites; Cats; Cell Line; Drug Interactions; Drug Resistance, Microbial; Immunodeficiency Virus, Feline; Lamivudine; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Proline; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Serine; Viral Plaque Assay; Zidovudine	1998
A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidine. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8 Topics: Anti-HIV Agents; Drug Resistance, Microbial; HeLa Cells; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Point Mutation; Proline; Reverse Transcriptase Inhibitors; Serine	1999

Article

Year

A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.

Journal of virology, 1998, Volume: 72, Issue:3

Topics: Amino Acid Sequence; Animals; Binding Sites; Cats; Cell Line; Drug Interactions; Drug Resistance, Microbial; Immunodeficiency Virus, Feline; Lamivudine; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Proline; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Serine; Viral Plaque Assay; Zidovudine

1998

A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidine.

Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

Topics: Anti-HIV Agents; Drug Resistance, Microbial; HeLa Cells; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Point Mutation; Proline; Reverse Transcriptase Inhibitors; Serine

1999